Resultats de la cerca - Kim TE

Dose-proportional pharmacokinetic properties of GLA5PR GLARS-NF1 controlled-release pregabalin in healthy Korean volunteers: a randomized, open, single-dose, parallel study per Shin KH, Jeon JY, Jang K, Kim TE, Kim MG

Connect to this object online.

Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteers per Yoon S, Lee H, Kim TE, Lee S, Chee DH, Cho JY, Yu KS, Jang IJ

Connect to this object online.

Effect of epigallocatechin-3-gallate, major ingredient of green tea, on the pharmacokinetics of rosuvastatin in healthy volunteers per Kim TE, Ha N, Kim Y, Kim H, Lee JW, Jeon JY, Kim MG

Connect to this object online.

Lack of the effect of lobeglitazone, a peroxisome proliferator-activated receptor-γ agonist, on the pharmacokinetics and pharmacodynamics of warfarin per Jung JA, Lee SY, Kim TE, Kim JR, Kim C, Huh W, Ko JW

Connect to this object online.

Effect of green tea catechins on the pharmacokinetics of digoxin in humans per Kim TE, Shin KH, Park JE, Kim MG, Yun YM, Choi DH, Kwon KJ, Lee J

Connect to this object online.

Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers per Gu N, Park MK, Kim TE, Bahng MY, Lim KS, Cho SH, Yoon SH, Cho JY, Jang IJ, Yu KS

Connect to this object online.

A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis per Jung JA, Kim TE, Lee H, Jeong BH, Park HY, Jeon K, Kwon OJ, Ko JW, Choi R, Woo HI, Koh WJ, Lee SY

Connect to this object online.